Dr. Brian Harkins Becomes the First Person to Use New AirSeal Abdomen Surgical Technology: Lowering Air Pressure in Cavities
Tomball, April 04, 2022 (GLOBE NEWSWIRE) -- A leading surgeon based in Tomball, Texas, has become the first person to...
Month: April 2022
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank Castellum, Inc. (OTC: ONOV) announces that it has...
INmune Bio, Inc. Highlights INKmune™ Data Featured in NK Cells in Solid Tumors Workshop at Innate Killer Summit
INKmune™, unlike IL15 and other NK-activating cytokines, upregulates all mitochondrial survival proteins and more than 40 nutrient receptors on the...
Allied Corp Commends Colombian Government for Announcing the Final Approval of the Regulations for the Export of Cannabis From Colombia
KELOWNA, British Columbia, April 04, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Dyadic International to Present at Upcoming Scientific Medical Meetings
JUPITER, Fla., April 04, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology...
Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference
Company announcement – No. 11 / 2022 Zealand Pharma to Participate in 21st Annual Needham Virtual Healthcare Conference Copenhagen, DK and Boston, MA,...
Vaxcyte Doses First Participants in Phase 2 Portion of Ongoing VAX-24 Phase 1/2 Clinical Proof-of-Concept Study in Adults
-- Following Prespecified Review of Phase 1 Safety and Tolerability Data, Independent Data Monitoring Committee Recommends Study Proceed as Planned...
eFFECTOR Therapeutics Announces Transition in Clinical Leadership
Premal Patel, M.D., Ph.D., chief medical officer, has resigned to pursue a new career opportunity Robert Sikorski, M.D., Ph.D., to...
eGenesis Appoints Eliezer Katz, M.D., FACS, as Chief Medical Officer
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- eGenesis, a gene-editing and genome-engineering company developing human-compatible organs and cells, today...
Journey Medical Corporation to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
SCOTTSDALE, Ariz., April 04, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical company that...
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
BERKELEY HEIGHTS, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
Acer Therapeutics’ EDSIVO™ (celiprolol) Granted FDA Breakthrough Therapy Designation for Vascular Ehlers-Danlos Syndrome
Discussions ongoing with FDA through special protocol assessment (SPA) seeking agreement on planned pivotal Phase 3 DiSCOVER trial with initiation...
Checkpoint Therapeutics to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities
WALTHAM, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology...
Genocea Biosciences to Host Investor Webinar
CAMBRIDGE, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies,...
X4 Pharmaceuticals to Present at April Investor Conferences
BOSTON, April 04, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel...
Emerging Markets Report: No One Should be Alone
A New Marketing Plan Potentially Could be the Bridge to a Better Tomorrow for Aging Americans An Emerging Markets Sponsored...
COMPASS Pathways to participate in Needham Healthcare conference
LONDON, April 04, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating...
Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference
WATERTOWN, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Amedisys Completes Acquisition of Evolution Health
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,...
Amedisys Completes Acquisition of Home Health Assets from AssistedCare Home Health and AssistedCare of the Carolinas
BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,...
